The Associate Director of Clinical Operations will lead the planning and execution of early-stage clinical trials, with a primary focus on Oncology programs. This role involves managing cross-functional teams, overseeing CROs and vendors, and ensuring compliance with GCP standards throughout the drug development lifecycle.
The Director of Clinical Operations will provide strategic and operational leadership for global Phase 3 studies, ensuring accountability for study execution, quality, and budget. Additionally, the role involves direct line management of clinical operations staff and fostering a culture of operational excellence and cross-functional collaboration.
The Senior Manager will serve as the lead data manager for clinical studies, overseeing data management activities from start-up through database lock. They will partner with cross-functional teams and CROs to ensure high data quality, manage database builds, and mitigate risks throughout the study lifecycle.
The Senior Director, Medical Monitor will provide medical oversight for late-stage respiratory clinical trials, ensuring patient safety and protocol compliance. They will also collaborate cross-functionally to interpret clinical data and contribute to regulatory filings and study reports.
The Senior Director will set the strategic direction and lead the execution of analytical development for biologics programs within a virtual development model. They will manage external CDMO partnerships, oversee GMP compliance, and ensure analytical strategies support commercialization readiness.
The Vice President will lead late-stage Immunology and Inflammation programs, shaping integrated development strategies and guiding cross-functional teams through regulatory submission. They are responsible for building a high-performing team of physicians and scientists while ensuring clinical excellence and alignment with corporate objectives.
The Director will serve as the clinical science lead for respiratory programs, driving protocol development, study execution, and regulatory documentation. They will collaborate with cross-functional teams to ensure data quality, participant safety, and alignment with clinical development milestones.
